Bovine infectious keratoconjunctivitis, commonly known as cattle pink eye, is a highly prevalent and economically damaging condition that affects cattle herds worldwide. This highly contagious ocular infection primarily targets the clear cornea and the surrounding conjunctiva, leading to significant discomfort, impaired vision, and reduced productivity in affected animals. The primary causative agent is the bacterium *Moraxella bovis*, although secondary infections and contributing factors often complicate the clinical picture. Understanding the nuances of this disease is the first step toward effective management and mitigation of its impact on a farming operation.
Identifying the Clinical Signs and Symptoms
Early detection is critical for controlling an outbreak and minimizing economic losses. The hallmark sign of cattle pink eye is the abrupt onset of excessive tearing and a characteristic watery discharge from the affected eye. This is frequently followed by intense inflammation, causing the eye to appear red and swollen. As the condition progresses, the cornea becomes cloudy and develops a characteristic grayish-white ulcer. In severe cases, the ulcer may rupture, potentially leading to permanent scarring or even blindness if left untreated. Affected animals will often exhibit photophobia, squinting, and reluctance to move into bright sunlight due to the pain it causes.
Primary Causes and Contributing Risk Factors
While *Moraxella bovis* is the primary bacterial culprit, the disease rarely occurs in a vacuum and is typically triggered by a combination of environmental and managemental stressors. Flies are the primary mechanical vectors, transferring the bacteria from the eyes of infected animals to healthy ones. Environmental irritants such as dust, tall grass, and ultraviolet radiation from intense sunlight cause physical damage to the corneal surface, creating an entry point for the bacteria. Additionally, the presence of ocular irritants like grass seeds or foreign matter can exacerbate the condition. Young cattle in crowded pasture settings are generally at the highest risk of contracting the infection.
Consequences for Herd Health and Economics
The impact of cattle pink eye extends far beyond the visible symptoms and directly affects the financial health of a farm. The pain and visual impairment caused by the infection lead to significant production losses, as affected cattle reduce their grazing time and feed intake. This results in poor weight gain and reduced milk yield in lactating animals. Furthermore, the treatment costs associated with veterinary visits, medications, and the labor required for handling and administering care can accumulate rapidly. In severe cases where the cornea is permanently damaged, the animal may need to be culled, representing a total loss of the investment in that animal.
Treatment Options and Medical Interventions
Systemic Antibiotics and Anti-inflammatories
Systemic treatment is often necessary to address the infection effectively and reduce inflammation. Long-acting oxytetracycline antibiotics are a common and widely used choice, providing prolonged therapeutic action with fewer individual injections. Alternatively, florfenicol or potentiated sulfonamides may be administered according to veterinary guidance. To manage the significant ocular pain and inflammation, non-steroidal anti-inflammatory drugs (NSAIDs) are frequently prescribed. These medications not only alleviate discomfort but also encourage the animal to resume normal grazing behavior, which is vital for recovery.
Topical Therapies and Localized Care
Direct treatment of the ocular lesion is a cornerstone of therapy. Ocular ointments containing antibiotics such as tetracycline or sulfonamide are applied directly to the eye, creating a high concentration of the drug at the site of infection. In many protocols, the affected eye is patched after the application of the ointment to protect the cornea from light and prevent the animal from rubbing the eye, which can worsen the ulcer. Some modern treatment regimens utilize subconjunctival injections of antibiotics to deliver a high dose of medication directly into the affected area, promoting faster healing.
